Amalgamated Bank’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,848
| Closed | -$6K | – | 1980 |
|
|
2025
Q4 | $6K | Buy |
2,848
+41
| +1% | +$118 | ﹤0.01% | 2630 |
|
|
2025
Q3 | $10K | Hold |
2,807
| – | – | ﹤0.01% | 2464 |
|
|
2025
Q2 | $6K | Hold |
2,807
| – | – | ﹤0.01% | 2643 |
|
|
2025
Q1 | $3K | Hold |
2,807
| – | – | ﹤0.01% | 2779 |
|
|
2024
Q4 | $4K | Hold |
2,807
| – | – | ﹤0.01% | 2780 |
|
|
2024
Q3 | $10K | Hold |
2,807
| – | – | ﹤0.01% | 2442 |
|
|
2024
Q2 | $13K | Hold |
2,807
| – | – | ﹤0.01% | 2297 |
|
|
2024
Q1 | $21K | Sell |
2,807
-4,951
| -64% | -$41.1K | ﹤0.01% | 2101 |
|
|
2023
Q4 | $79K | Sell |
7,758
-265
| -3% | -$2.33K | ﹤0.01% | 2077 |
|
|
2023
Q3 | $63K | Buy |
8,023
+1,226
| +18% | +$10.5K | ﹤0.01% | 2149 |
|
|
2023
Q2 | $56K | Sell |
6,797
-312
| -4% | -$2.72K | ﹤0.01% | 2272 |
|
|
2023
Q1 | $52K | Sell |
7,109
-1,687
| -19% | -$15K | ﹤0.01% | 2293 |
|
|
2022
Q4 | $78K | Hold |
8,796
| – | – | ﹤0.01% | 2234 |
|
|
2022
Q3 | $108K | Buy |
8,796
+86
| +1% | +$1.34K | ﹤0.01% | 2115 |
|
|
2022
Q2 | $103K | Sell |
8,710
-2,442
| -22% | -$32.7K | ﹤0.01% | 2154 |
|
|
2022
Q1 | $212K | Sell |
11,152
-883
| -7% | -$16.4K | ﹤0.01% | 1916 |
|
|
2021
Q4 | $320K | Sell |
12,035
-130
| -1% | -$4.47K | ﹤0.01% | 1784 |
|
|
2021
Q3 | $500K | Sell |
12,165
-750
| -6% | -$41.1K | ﹤0.01% | 1582 |
|
|
2021
Q2 | $732K | Buy |
12,915
+3,411
| +36% | +$126K | 0.01% | 1436 |
|
|
2021
Q1 | $399K | Sell |
9,504
-311
| -3% | -$17.7K | 0.02% | 1106 |
|
|
2020
Q4 | $688K | Buy |
9,815
+53
| +0.5% | +$2.18K | 0.03% | 780 |
|
|
2020
Q3 | $274K | Buy |
9,762
+888
| +10% | +$28.9K | 0.01% | 1155 |
|
|
2020
Q2 | $262K | Buy |
+8,874
| New | +$232K | 0.01% | 1187 |
|
|
2020
Q1 | – | Sell |
-9,625
| Closed | -$285K | – | 1709 |
|
|
2019
Q4 | $285K | Buy |
9,625
+730
| +8% | +$18.2K | 0.01% | 1437 |
|
|
2019
Q3 | $202K | Sell |
8,895
-59
| -0.7% | -$1.46K | ﹤0.01% | 1546 |
|
|
2019
Q2 | $222K | Buy |
+8,954
| New | +$214K | 0.01% | 1526 |
|
|
2018
Q3 | – | Sell |
-6,951
| Closed | -$249K | – | 1498 |
|
|
2018
Q2 | $249K | Buy |
+6,951
| New | +$246K | 0.01% | 1437 |
|
Other funds holding EDIT
VCM
VPM
N
OM
Amalgamated Bank's EDIT Position: Q1 2026 in Review
Amalgamated Bank sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 2,848 shares — an estimated $6K sold.
Amalgamated Bank first reported a position in EDIT in Q2 2018 and held it in 27 quarters. The position peaked at $732K in Q2 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.
- Amalgamated Bank reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 2,848 Editas Medicine shares in Q1 2026, an estimated $6K.
- Amalgamated Bank first reported a position in Editas Medicine in Q2 2018 and held it in 27 quarters.
- Amalgamated Bank's Editas Medicine position peaked at $732K in Q2 2021.
- 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.